Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 5.16% · OPTIONAL
· Electromedical & Electrotherapeutic Apparatus
RESEARCH SNAPSHOTMedtronic plc's latest supported as-filed period reports revenue of $9.8B. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 5.16% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 18.38% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 13.73% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 63.70% · OPTIONAL
Level · gp.fundamentals.operating_margin
Raw value 18.08% · CORE
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 1.28% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents increased 32.8%; Operating cash flow increased 64.8%.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 8.7%; Operating margin moved 361 bp lower; Operating income decreased 11.1%.
3 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 13.7%; Operating margin moved 124 bp higher; Operating income increased 22.1%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Inventory increased 12.5%; Inventory / revenue moved 231 bp higher.
2 evidence-backed componentsOperating cash flow changed +64.8% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
MDT · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001628280-26-060473SEC ↗8-KSep 1, 2026Period Sep 1, 20260001628280-26-059697SEC ↗4Aug 24, 2026Period Aug 20, 20260001984186-26-000008SEC ↗4Aug 4, 2026Period Jul 31, 20260002061393-26-000012SEC ↗4Aug 4, 2026Period Jul 31, 20260002028475-26-000010SEC ↗4Aug 4, 2026Period Jul 31, 20260002137804-26-000004SEC ↗4Aug 4, 2026Period Aug 3, 20260001964281-26-000004SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 20, 2026Filed Aug 24, 2026 | Marinaro MichaelEVP, Pres MedSurg and Americas | Tax WithholdingDirect | 1,084 | $92 | $100,053 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Free-cash-flow proxy changed +120.9% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Operating margin changed -361 basis points from the comparable as-filed period.
Net income changed +41.3% from the comparable as-filed period.
Operating income changed +22.1% from the comparable as-filed period.
Inventory / revenue changed -491 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed +124 basis points from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-07-31. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0002056622-26-000003